Li-hua Qiu

Key Laboratory Of Cancer Prevention And Therapy
Tianjin, 300360, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Research Advances of Immunotherapy for Follicular Lymphoma --Review

Research Advances of Immunotherapy for Follicular Lymphoma --Review

Journal: Zhongguo shi yan xue ye xue za zhi

Published: April 09, 2022

Clinical Significance of EBV-DNA Copy Number in EBV Positive Lymphoma Patients

Clinical Significance of EBV-DNA Copy Number in EBV Positive Lymphoma Patients

Journal: Zhongguo shi yan xue ye xue za zhi

Published: December 11, 2021

Research Progression of Subcutaneous Panniculitis-like T-Cell Lymphoma--Review

Research Progression of Subcutaneous Panniculitis-like T-Cell Lymphoma--Review

Journal: Zhongguo shi yan xue ye xue za zhi

Published: February 08, 2021

Necroptosis as a potential therapeutic target in multiple organ dysfunction syndrome.

Necroptosis as a potential therapeutic target in multiple organ dysfunction syndrome.

Journal: Oncotarget

Published: March 24, 2017

Expression and prognostic value of regulatory T cells and M2 macrophages in diffuse large B-cell lymphoma tissues

Expression and prognostic value of regulatory T cells and M2 macrophages in diffuse large B-cell lymphoma tissues

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: October 15, 2013

Evaluation of toxicity and single-dose pharmacokinetics of intravenous ursolic acid liposomes in healthy adult volunteers and patients with advanced solid tumors.

Evaluation of toxicity and single-dose pharmacokinetics of intravenous ursolic acid liposomes in healthy adult volunteers and patients with advanced solid tumors.

Journal: Expert opinion on drug metabolism & toxicology

Published: November 09, 2012

Efficacy and survival status of retuximab-NCE regimen treatment in patients with relapsed or refractory B cell non-Hodgkin's lymphoma

Efficacy and survival status of retuximab-NCE regimen treatment in patients with relapsed or refractory B cell non-Hodgkin's lymphoma

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: July 12, 2012

Expression of Cdc7 and mcm2 as a marker for proliferation and prognosis in diffuse large B cell lymphoma

Expression of Cdc7 and mcm2 as a marker for proliferation and prognosis in diffuse large B cell lymphoma

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: February 21, 2012

Nimotuzumab in combination with chemotherapy in patients with advanced non-small cell lung cancer

Nimotuzumab in combination with chemotherapy in patients with advanced non-small cell lung cancer

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: February 14, 2012

Efficacy and safety of palonosetron versus tropisetron in the prevention of highly emetogenic chemotherapy-induced acute and delayed vomiting in Chinese cancer patients

Efficacy and safety of palonosetron versus tropisetron in the prevention of highly emetogenic chemotherapy-induced acute and delayed vomiting in Chinese cancer patients

Journal: Zhonghua yi xue za zhi

Published: February 11, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026